Oxygenation and Anemia

Introduction to Hypoxemia

• Hypoxemia is a condition where the body, or a region of the body, is deprived of adequate oxygen supply, and it can be classified into four main types: hypoxemic, anemic, stagnant, and histotoxic hypoxia, each requiring distinct management approaches to prevent tissue injury and death, as recognized by the American Thoracic Society, European Respiratory Society, and other medical authorities 1, 2, 3, 4
• The prevalence of hypoxemia is 24.5% in neonates, 12.1% in children, and 10.8% in adults in low and middle-income countries, according to the World Health Organization 2
• Hypoxemia is associated with 4.84 times higher odds of death compared to non-hypoxemic patients and requires prompt identification and management, as reported by the American College of Chest Physicians 2, 1

Causes and Effects of Hypoxemia

• The four main types of hypoxia are caused by different underlying mechanisms, including reduced partial pressure of oxygen in the blood, reduced hemoglobin available for oxygen transport, inadequate blood flow to tissues, and disrupted cellular metabolism, respectively 1
• Hypoxemic hypoxia is caused by reduced partial pressure of oxygen in the blood, resulting from V/Q mismatch, right-to-left shunts, alveolar hypoventilation, or diffusion impairment, and it presents as Type 1 respiratory failure (PaO₂ <8 kPa or 60 mmHg with normal/low PaCO₂) 1
• Anemic hypoxia is caused by reduced hemoglobin available for oxygen transport, resulting in normal PaO₂ and SpO₂ but reduced oxygen content, and it includes carbon monoxide poisoning which impairs hemoglobin's ability to bind oxygen 1
• Stagnant (circulatory) hypoxia is caused by inadequate blood flow to tissues, occurring in low cardiac output states, peripheral vascular disease, and cold exposure 1
• Histotoxic (cytopathic) hypoxia is caused by the inability of tissues to use oxygen due to disrupted cellular metabolism, and it can occur in sepsis due to mitochondrial dysfunction ("cytopathic dysoxia") 1

Assessment of Hypoxemia

• Pulse oximetry (SpO₂) has a normal range of 95-100%, and a clinical hypoxemia threshold of SpO₂ <90%, but it may be less accurate in anemic hypoxia, carbon monoxide poisoning, and in patients with deeply pigmented skin 2
• Arterial blood gas analysis is the gold standard for assessing hypoxemia, with a normal PaO₂ of 80-100 mmHg (10.6-13.3 kPa) and a hypoxemia threshold of PaO₂ <60 mmHg (8 kPa) 1
• Tissue perfusion assessment can be done using capillary refill time, lactate levels, base deficit, and mixed venous oxygen saturation (SvO₂) 1
• Shunting can be assessed through shunt fraction calculation, which measures the percentage of cardiac output that bypasses ventilated alveoli, providing a quantitative measure of the extent of shunting 3

Management of Hypoxemia

• Oxygen therapy is the primary intervention for hypoxemic hypoxia, with a target SpO₂ of 94-98% for most acutely ill patients, and it should be used with caution in patients at risk of hypercapnia (e.g., COPD) 1
• Ventilatory support, including PEEP and prone positioning, can be used to recruit collapsed alveoli and improve V/Q matching in severe cases 1
• Treating the underlying cause of hypoxia, such as bronchospasm, pneumonia, or pulmonary edema, is crucial for effective management 1
• Blood transfusion can be used to increase oxygen-carrying capacity in severe anemia, and iron supplementation and erythropoietin can be used to treat iron deficiency anemia and anemia of chronic disease or renal failure, respectively 1
• Hyperbaric oxygen can be used to enhance oxygen dissolution in plasma in cases of carbon monoxide poisoning 1
• Optimizing cardiac output, improving regional perfusion, and maintaining adequate perfusion pressure are essential for managing stagnant hypoxia 1
• Antidotes for toxins, such as hydroxocobalamin or sodium thiosulfate for cyanide poisoning, can be used to treat histotoxic hypoxia 1
• Metabolic support in sepsis, including early goal-directed therapy, source control, and appropriate antimicrobial therapy, can help manage histotoxic hypoxia 1
• Positive end-expiratory pressure (PEEP) helps by recruiting collapsed alveoli, reducing shunt fraction, and improving ventilation-perfusion matching in ARDS patients, as recommended by the American Thoracic Society 3
• Target saturation should be 88-92% in patients at risk of hypercapnia (e.g., COPD), according to available guidelines 1, 4